Primary cutaneous follicle centre lymphoma natural history, complications and prognosis: Difference between revisions
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{AS}} | {{CMG}}; {{AE}} {{AS}} | ||
==Overview== | ==Overview== | ||
Prognosis is generally excellent, and the 5-year survival rate of patients with primary cutaneous follicle centre lymphoma is approximately 97%. | |||
==Prognosis== | ==Prognosis== | ||
* | * Prognosis is generally excellent, and the 5-year survival rate of patients with primary cutaneous follicle centre lymphoma is approximately 97%. | ||
* The International Extranodal Lymphoma Study Group identified three prognostic factors, that are used to assess a cutaneous lymphoma international prognostic index (CLIPI), which is [[prognosis|prognostic]] of disease-free status.<ref name="Wilcox2015"/> | * The International Extranodal Lymphoma Study Group identified three prognostic factors, that are used to assess a cutaneous lymphoma international prognostic index (CLIPI), which is [[prognosis|prognostic]] of disease-free status.<ref name="Wilcox2015">{{cite journal |authors=Wilcox RA |title=Cutaneous B-cell lymphomas: 2015 update on diagnosis, risk-stratification, and management |journal=Am. J. Hematol. |volume=90 |issue=1 |pages=73–6 |year=2015 |pmid=25535037 |doi=10.1002/ajh.23863 |url=}}</ref> | ||
:* Elevated [[Lactate dehydrogenase|LDH]] | :* Elevated [[Lactate dehydrogenase|LDH]] | ||
:* More than two skin lesions | :* More than two skin lesions | ||
Revision as of 14:17, 2 March 2016
|
Primary cutaneous follicle centre lymphoma Microchapters |
|
Differentiating Primary cutaneous follicle centre lymphoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Primary cutaneous follicle centre lymphoma natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Primary cutaneous follicle centre lymphoma natural history, complications and prognosis |
|
FDA on Primary cutaneous follicle centre lymphoma natural history, complications and prognosis |
|
CDC on Primary cutaneous follicle centre lymphoma natural history, complications and prognosis |
|
Primary cutaneous follicle centre lymphoma natural history, complications and prognosis in the news |
|
Blogs on Primary cutaneous follicle centre lymphoma natural history, complications and prognosis |
|
Directions to Hospitals Treating Splenic marginal zone lymphoma |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
Prognosis is generally excellent, and the 5-year survival rate of patients with primary cutaneous follicle centre lymphoma is approximately 97%.
Prognosis
- Prognosis is generally excellent, and the 5-year survival rate of patients with primary cutaneous follicle centre lymphoma is approximately 97%.
- The International Extranodal Lymphoma Study Group identified three prognostic factors, that are used to assess a cutaneous lymphoma international prognostic index (CLIPI), which is prognostic of disease-free status.[1]
- Elevated LDH
- More than two skin lesions
- Nodular lesions
References
- ↑ Wilcox RA (2015). "Cutaneous B-cell lymphomas: 2015 update on diagnosis, risk-stratification, and management". Am. J. Hematol. 90 (1): 73–6. doi:10.1002/ajh.23863. PMID 25535037.